Lupin
LUPIN · Pharma > Pharmaceuticals & Drugs · Chairman: Manju D Gupta · MD: Nilesh Gupta · Listing date: Sept. 11, 2001 · Employees: 18573 · Mumbai · http://www.lupin.com

Stock Price vs Company Growth
1d
2.2%
1w
1.5%
1m
2.2%
3m
5.5%
6m
10.6%
1y
25.6%
5y
20.6%
10y
1.1%
all
17.3%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec10Jun14Dec17Jun21Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

2,012 2.2%
1,774
2,225
Company Overview

Sales
22,002 Cr
Growth: 13.7%
Profit after Tax
2,869 Cr
Growth: 9.2%
Large Cap
91,863 Cr
P/E: 32.1x
Industry P/E: 29.6x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 22,002
Growth 13.7%
EBITDA 22.4%
P/S 4.2x
Dividend 0.4%
P/E 32.1x
Book Value ₹ 368
PEG Ratio 2.3x
ROE 18.5%
P/B 5.5x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
6.99 %
Hdfc Trustee Company Limited-Hdfc Flexi Cap Fund
4.28 %
Government Pension Fund Global
1.21 %
Franklin India Focused Equity Fund
1.13 %
Icici Prudential Life Insurance Company Limited
1.13 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21Mar22Jun24
Promoters
Lupin Investments Pvt Ltd
45.3 %
Manju D Gupta
0.85 %
Nilesh D Gupta
0.2 %
Anuja Gupta
0.16 %
Desh Bandhu Gupta Huf
0.14 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21Mar22Jun24
Others
Rakesh Jhunjhunwala
1.6 %
Nps Trust - A/C Lic Pension Fund Sch-State Govt
1.48 %
Iepf
0.15 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21Mar22Jun24
Increase    Decrease    No change
Company Profile Detailed

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.Products and services offered by the companyGlobal FormulationsActive Pharmaceuticals Ingredients (API)BiotechSpecialty BusinessOver The Counter (OTC)Global Manufacturing & Supply ChainAwards2007: Cardinal Health Conferred Two Awards - The ‘Trade Representative Of The Year’ And The ‘Quality Supplier Award’ To Lupin Pharmaceuticals Inc.
Investors (232)
Followers (56)